secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2026-06-09T20:05:24+00:00
Accession:  0001213900-26-066782
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics receives Nasdaq bid price deficiency notice; 180 days to cure
--------------------------------------------------------------------------------

- On June 3, 2026, Nasdaq notified Jasper that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has until November 30, 2026 to regain compliance by achieving $1.00+ close for at least 10 consecutive days.
- If not cured by Nov 30, Jasper may qualify for an additional 180-day period subject to other listing standards and potential reverse stock split.
- Failure to cure could result in delisting of common stock and warrants from Nasdaq Capital Market.
- Jasper intends to monitor bid price and consider options including a reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390026066782/0001213900-26-066782-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390026066782/ea0294010-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-066782

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer